CONTACT INFORMATIONBIOGRAPHYCREDENTIALSAWARDSPATENTSPUBLICATIONSRachel A. F. Wozniak, M.D., Ph.D.Contact InformationPhone NumbersAppointment: (585) 273-3937A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsResearch LabsVisit Lab WebsiteLocationsUniversity of Rochester Medical CenterSchool of Medicine and Dentistry601 Elmwood Ave, Box 659Rochester, NY 14642Faculty AppointmentsAssistant Professor - Department of Ophthalmology (SMD) Patient Care SettingOphthalmologyBiographyRachel Wozniak, MD, PhD is a member of the Flaum Eye Institute's Cornea Service. She provides expert and compassionate medical and surgical care to patients challenged by hereditary and infectious corneal disease, anterior segment injuries, complications of systemic disease, cataract, and ocular surface disease. Dr. Wozniak treats both children and adults and enjoys working with her colleagues from other FEI subspecialties to deliver comprehensive eye care solutions that maximize patient outcomes. Dr. Wozniak earned her medical degree and completed a doctorate in genetics at Tufts University School of Medicine. She completed her ophthalmology residency at the University of Rochester School Of Medicine and Dentistry's Flaum Eye Institute. Here she also went on to complete a fellowship in Cornea and External Disease at the Flaum Eye Institute under a Heed Ophthalmic Foundation Fellow Award. Besides her clinical pursuits, Dr. Wozniak is actively engaged in basic scientific research and has already authored an impressive list of peer-reviewed publications. Her particular area of research interest focuses on the pathogenesis of bacterial corneal infections and novel antimicrobial drug discovery. She is board certified through the American Board of Ophthalmology and a member of the American Academy of Ophthalmology, Women in Ophthalmology, the Association for Research in Vision and Ophthalmology and the American Society of Cataract and Refractive Surgery.CredentialsSpecialtiesOphthalmology - American Board of OphthalmologyEducation2012MD | Tufts University School of Medicine2012PHD | Tufts University School of MedicinePost-doctoral Training & Residency07/01/2016 - 07/31/2017Fellowship in Ophthalmology at University of Rochester Medical Center07/01/2013 - 06/30/2016Residency in Ophthalmology at University of Rochester Medical Center06/15/2012 - 06/15/2013Internship in Transitional Year at Cambridge Hospital-GMEVIEW ALL expand_moreAwards2016 - 2016Drug Development Delivery Pilot AwardLocation: University of Rochester, NY2016 - 2016ASCRS Foundation Research Award2016 - 2016Snell Ophthalmology Resident Investigator AwardLocation: University of Rochester, NY2016 - 2016Heed Ophthalmic Foundation Fellow Award2014 - 2014Young Investigator Track, ARVO/NAEVR Advocacy DayLocation: Washington DC2014 - 2014Heed Ophthalmic Foundation Resident RetreatLocation: Chicago, ILVIEW ALL expand_morePatentsPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: 3500254 Issue Date: Mar 23, 2022 Country: Europe Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: FR3500254 Issue Date: Mar 23, 2022 Country: France Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: DE3500254 Issue Date: Mar 23, 2022 Country: Germany Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: IT3500254 Issue Date: Mar 23, 2022 Country: Italy Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: NL3500254 Issue Date: Mar 23, 2022 Country: Netherlands Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: ES3500254 Issue Date: Mar 23, 2022 Country: Spain Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: GB3500254 Issue Date: Mar 23, 2022 Country: United Kingdom Invented By: Paul M Dunman, Rachel A WozniakPatent Title: Pharmaceutical Composition Containing Polymyxin B/Trimethoprim Based Therapeutics Patent #: 11,096,923 Issue Date: Aug 24, 2021 Country: United States Invented By: Paul M Dunman, Rachel A WozniakVIEW ALL expand_morePublicationsJournal Articles11/1/2022Meijome TE, Wozniak R, Kang L, Azzouz L, Niziol LM, Johnson WL, Kriegel M, Woodward MA. "Assessment of Keratitis Severity Using Quantitative Image Analysis in an In Vivo Murine Model of Staphylococcus aureus Bacterial Keratitis." Translational vision science & technology.. 2022 Nov 1; 11(11):12. 6/2022Maretz C, Green KM, Wozniak RAF. "Retained polyvinyl chloride fragments in the cornea following trauma." American journal of ophthalmology case reports.. 2022 Jun; 26:101561. Epub 2022 Apr 29. 5/2/2022Mei JA, Johnson W, Kinn B, Laskey E, Nolin L, Bhamare P, Stalker C, Dunman PM, Wozniak RAF. "Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates." Translational vision science & technology.. 2022 May 2; 11(5):26. VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with Rachel A. F. Wozniak, M.D., Ph.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Rachel A. F. Wozniak, M.D., Ph.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.